Literature DB >> 16595618

Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study.

D J Lehmann1, H Refsum, E Nurk, D R Warden, G S Tell, S E Vollset, K Engedal, H A Nygaard, A D Smith.   

Abstract

BACKGROUND: Among elderly people without dementia, the apolipoprotein E epsilon4 allele (APOE4) has been associated with cognitive deficit, particularly in episodic memory, but few reports are available on whether this association differs by sex.
METHODS: In a community-dwelling Norwegian cohort of 2181 elderly people (55% women), aged 70-74 years, episodic memory was examined in relation to sex and APOE4 zygosity, with the Kendrick Object Learning Test (KOLT).
RESULTS: Possession of at least one APOE4 allele had a modest, detrimental effect on episodic memory in women, whereas in men, heterozygotes were unaffected and homozygotes had markedly lower scores across the distribution of KOLT scores. This sex difference was found consistently in all analyses: on comparing means and medians, examining trends across quintiles, and studying the distribution of scores and the risk of cognitive impairment. Results were broadly similar when adjusted for known determinants of cognition and also when severely impaired participants were excluded. The adjusted odds ratio (OR) of cognitive impairment in women was shown to be 1.8 (95% confidence interval (CI): 1.1 to 2.8) for heterozygotes and 1.1 (0.3 to 3.7) for homozygotes; the adjusted OR in men was observed to be 1.1 (0.6 to 2.1) for heterozygotes and 10.7 (4.7 to 24) for homozygotes.
CONCLUSIONS: Although the harmful effect of APOE4 on episodic memory was modest in women, the risk was found to occur in about 30%. APOE4 was observed to have a dramatic effect on episodic memory in men, but only in homozygotes, who comprised about 3% of men: the whole male homozygous group showed a marked shift to lower memory scores.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595618      PMCID: PMC2077621          DOI: 10.1136/jnnp.2005.077818

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

1.  Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study.

Authors:  E L Helkala; K Koivisto; T Hanninen; M Vanhanen; K Kervinen; J Kuusisto; L Mykkanen; Y A Kesaniemi; M Laakso; P Riekkinen
Journal:  Neurosci Lett       Date:  1996-02-09       Impact factor: 3.046

2.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  The Hordaland homocysteine study: the opposite tails odds ratios reveal differential effects of gender and intake of vitamin supplements at high and low plasma total homocysteine concentrations.

Authors:  H Refsum; O Nygård; G Kvåle; P M Ueland; S E Vollset
Journal:  J Nutr       Date:  1996-04       Impact factor: 4.798

4.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

Authors:  T G Ohm; H Müller; H Braak; J Bohl
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

5.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.

Authors:  O Nygård; S E Vollset; H Refsum; I Stensvold; A Tverdal; J E Nordrehaug; M Ueland; G Kvåle
Journal:  JAMA       Date:  1995-11-15       Impact factor: 56.272

6.  The neuropsychological differentiation of patients with very mild Alzheimer's disease and/or major depression.

Authors:  G desRosiers; J R Hodges; G Berrios
Journal:  J Am Geriatr Soc       Date:  1995-11       Impact factor: 5.562

7.  Apolipoprotein E polymorphism and Alzheimer's disease.

Authors:  J Poirier; J Davignon; D Bouthillier; S Kogan; P Bertrand; S Gauthier
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

8.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

Authors:  H Payami; S Zareparsi; K R Montee; G J Sexton; J A Kaye; T D Bird; C E Yu; E M Wijsman; L L Heston; M Litt; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

9.  Apolipoprotein E and cognitive change in an elderly population.

Authors:  B T Hyman; T Gomez-Isla; M Briggs; H Chung; S Nichols; F Kohout; R Wallace
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

10.  Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.

Authors:  L A Farrer; L A Cupples; C M van Duijn; A Kurz; R Zimmer; U Müller; R C Green; V Clarke; J Shoffner; D C Wallace
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

View more
  25 in total

1.  Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.

Authors:  May A Beydoun; Adel Boueiz; Marwan S Abougergi; Melissa H Kitner-Triolo; Hind A Beydoun; Susan M Resnick; Richard O'Brien; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2010-07-08       Impact factor: 4.673

2.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

3.  Apolipoprotein ɛ4 Allele and Subjective Cognitive Functioning in Parents of Adults With Disabilities.

Authors:  Jieun Song; Marsha R Mailick; Jan S Greenberg
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-09-14       Impact factor: 4.077

4.  Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Authors:  Scott C Neu; Judy Pa; Walter Kukull; Duane Beekly; Amanda Kuzma; Prabhakaran Gangadharan; Li-San Wang; Klaus Romero; Stephen P Arneric; Alberto Redolfi; Daniele Orlandi; Giovanni B Frisoni; Rhoda Au; Sherral Devine; Sanford Auerbach; Ana Espinosa; Mercè Boada; Agustín Ruiz; Sterling C Johnson; Rebecca Koscik; Jiun-Jie Wang; Wen-Chuin Hsu; Yao-Liang Chen; Arthur W Toga
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

5.  In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.

Authors:  Sookjaroen Tangwongchai; Thitiporn Supasitthumrong; Solaphat Hemrunroj; Chavit Tunvirachaisakul; Phenphichcha Chuchuen; Natnicha Houngngam; Thiti Snabboon; Ittipol Tawankanjanachot; Yuthachai Likitchareon; Kamman Phanthumchindad; Michael Maes
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 6.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 7.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 8.  Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Authors:  Leo Ungar; Andre Altmann; Michael D Greicius
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

9.  Greater memory impairment in dementing females than males relative to sex-matched healthy controls.

Authors:  Shawn D Gale; Leslie Baxter; Juliann Thompson
Journal:  J Clin Exp Neuropsychol       Date:  2016-01-06       Impact factor: 2.475

10.  Evidence that the gene encoding insulin degrading enzyme influences human lifespan.

Authors:  Mun-Gwan Hong; Chandra Reynolds; Margaret Gatz; Boo Johansson; Jennifer C Palmer; Harvest F Gu; Kaj Blennow; Patrick G Kehoe; Ulf de Faire; Nancy L Pedersen; Jonathan A Prince
Journal:  Hum Mol Genet       Date:  2008-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.